Ensuring Investments In TB R&D Critical To Confronting Drug Resistance

PLOS Blogs’ “Speaking of Medicine”: Why Tuberculosis is an R&D priority
On World TB Day, which takes place annually on March 24, Grania Brigden, lead of the 3P Project at the International Union Against TB and Lung Disease, discusses the importance of developing new treatments for TB and highlights a new funding mechanism, the 3P Project, which aims to “incentivize collaboration research, reward investment in TB R&D, and develop shorter [TB treatment] regimens” (3/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.